Nephron

Founded in 1997, Nephron is a pharmaceutical manufacturer specializing in generic respiratory medications, including inhalation suspensions like racemic epinephrine and sodium bicarbonate IV injections. The company operates a state-of-the-art manufacturing facility designed for 24/7 production, ensuring a consistent supply of critical medicines. Nephron is committed to high-quality pharmaceutical manufacturing, addressing industry shortages and providing essential treatments. With a focus on patient care, their product portfolio supports the treatment of various respiratory conditions. Meet Nephron's team to understand the expertise driving their operations and commitment to public health. The company's dedication extends to producing medical-grade gloves and supporting electronic ordering systems, enhancing healthcare accessibility and efficiency.

Nephron operates across 4 locations, employing between 1,000 and 5,000 individuals. This scale supports their extensive manufacturing capabilities, which include producing industry-leading products and offering outsourcing services. Their product range encompasses essential pharmaceuticals designed for patient use, with a particular emphasis on respiratory health. The company's operational model is built for high-volume, round-the-clock production, ensuring that vital medications are available when needed. This robust infrastructure allows Nephron to serve a broad market, contributing significantly to the pharmaceutical supply chain and patient well-being. Their commitment to quality and reliability underpins their reputation in the healthcare sector.

The company generates substantial revenue, with reported figures reaching $398.6M. This financial strength supports their ongoing investment in advanced manufacturing technologies and product development. Nephron competes within a dynamic pharmaceutical landscape, facing established players and emerging innovators. Their strategic focus on generic respiratory medications positions them as a key provider in aView more...